trimetazidine has been researched along with inositol in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Grynberg, A; Lucien, A; Sentex, E; Sergiel, JP | 2 |
3 other study(ies) available for trimetazidine and inositol
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Trimetazidine increases phospholipid turnover in ventricular myocyte.
Topics: Animals; Arachidonic Acids; Carbon Radioisotopes; Cells, Cultured; Chromatography, Thin Layer; Ethanolamine; Fatty Acids; Heart Ventricles; Inositol; Phospholipids; Rats; Rats, Wistar; Scintillation Counting; Trimetazidine; Vasodilator Agents | 1997 |
Is the cytoprotective effect of trimetazidine associated with lipid metabolism?
Topics: Animals; Cells, Cultured; Choline; Chromatography, Gas; Ethanolamine; Fatty Acids; Inositol; Linoleic Acid; Myocardial Ischemia; Myocardium; Oleic Acid; Phosphatidylethanolamines; Phosphatidylinositols; Phospholipids; Rats; Rats, Wistar; Stearic Acids; Trimetazidine; Vasodilator Agents | 1998 |